371
Views
15
CrossRef citations to date
0
Altmetric
Original Article

Colostrum and mature breast milk analysis of serum irisin and sterol regulatory element-binding proteins-1c in gestational diabetes mellitus

ORCID Icon, , &
Pages 2993-2999 | Received 16 Oct 2017, Accepted 15 Mar 2018, Published online: 02 Apr 2018

References

  • Fatima SS, Rehman R, Alam F, et al. Gestational diabetes mellitus and the predisposing factors. J Pak Med Assoc. 2017;67:261–265.
  • Lowe WL, Jr., Karban J. Genetics, genomics and metabolomics: new insights into maternal metabolism during pregnancy. Diabet Med. 2014;31:254–262.
  • Harder T, Bergmann R, Kallischnigg G, et al. Duration of breastfeeding and risk of overweight: a meta-analysis. Am J Epidemiol. 2005;162:397–403.
  • Hamosh M. Bioactive factors in human milk. Pediatr Clin North Am. 2001;48:69–86.
  • Boström PA, Fernández-Real JM, Mantzoros C. Irisin in humans: recent advances and questions for future research. Metab Clin Exp. 2014;63:178–180.
  • Boström P, Wu J, Jedrychowski MP, et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature. 2012;481:463–468.
  • Stanford KI, Middelbeek RJ, Townsend KL, et al. Brown adipose tissue regulates glucose homeostasis and insulin sensitivity. J Clin Invest. 2013;123:215–223.
  • So WY, Leung PS. Irisin ameliorates hepatic glucose/lipid metabolism and enhances cell survival in insulin-resistant human HepG2 cells through adenosine monophosphate-activated protein kinase signaling. Int J Biochem Cell Biol. 2016;78:237–247.
  • Garcés MF, Peralta JJ, Ruiz-Linares CE, et al. Irisin levels during pregnancy and changes associated with the development of preeclampsia. J Clin Endocrinol Metab. 2014;99:2113–2119.
  • Aydin S, Kuloglu T, Aydin S. Copeptin, adropin and irisin concentrations in breast milk and plasma of healthy women and those with gestational diabetes mellitus. Peptides. 2013;47:66–70.
  • Yuksel MA, Oncul M, Tuten A, et al. Maternal serum and fetal cord blood irisin levels in gestational diabetes mellitus. Diabetes Res Clin Pract. 2014;104:171–175.
  • Kuzmicki M, Telejko B, Lipinska D, et al. Serum irisin concentration in women with gestational diabetes. Gynecol Endocrinol. 2014;30:636–639.
  • Çağlar M, Göksu M, Isenlik BS, et al. Irisin in idiopathic foetal growth restriction. J Endocrinol Invest. 2014;37:619–624.
  • Piya MK, Harte AL, Sivakumar K, et al. The identification of irisin in human cerebrospinal fluid: influence of adiposity, metabolic markers, and gestational diabetes. Am J Physiol Endocrinol Metab. 2014;306:E512–E518.
  • Ebert T, Stepan H, Schrey S, et al. Serum levels of irisin in gestational diabetes mellitus during pregnancy and after delivery. Cytokine. 2014;65:153–158.
  • Griffin MJ, Sul HS. Insulin regulation of fatty acid synthase gene transcription: roles of USF and SREBP-1c. IUBMB Life. 2004;56:595–600.
  • Urban G, Marinoni E, Di Iorio R, et al. New placental factors: between implantation and inflammatory reaction. Early Pregnancy. 2001;5:70–71.
  • Janowski BA. The hypocholesterolemic agent LY295427 up-regulates INSIG-1, identifying the INSIG-1 protein as a mediator of cholesterol homeostasis through SREBP. Proc Natl Acad Sci USA. 2002;99:12675–12680.
  • International Association of Diabetes and Pregnancy Study Groups Consensus Panel, Metzger BE, Gabbe SG, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33:676–682.
  • Brunner S, Schmid D, Zang K, et al. Breast milk leptin and adiponectin in relation to infant body composition up to 2 years. Pediatr Obes. 2015;10:67–73.
  • Kragstrup TW, Vorup-Jensen T, Deleuran B, et al. A simple set of validation steps identifies and removes false results in a sandwich enzyme-linked immunosorbent assay caused by anti-animal IgG antibodies in plasma from arthritis patients. Springerplus. 2013;2:263.
  • Selby C. Interference in immunoassay. Ann Clin Biochem. 1999;36:704–721.
  • Snehalatha C, Viswanathan V, Ramachandran A. Cutoff values for normal anthropometric variables in Asian Indian adults. Diabetes Care. 2003;26:1380–1384.
  • Lee HJ, Lee JO, Kim N, et al. Irisin, a novel myokine, regulates glucose uptake in skeletal muscle cells via AMPK. Mol Endocrinol. 2015;29:873–881.
  • Zhang Y, Song H, Zhang Y, et al. Irisin inhibits atherosclerosis by promoting endothelial proliferation through microRNA126‐5p. J Am Heart Assoc. 2016;5:e004031.
  • Tang H, Yu R, Liu S, et al. Irisin inhibits hepatic cholesterol synthesis via AMPK-SREBP2 signaling. EBioMedicine. 2016;6:139–148.
  • Qiao X, Nie Y, Ma Y, et al. Irisin promotes osteoblast proliferation and differentiation via activating the MAP kinase signaling pathways. Sci Rep. 2016;6:18732.
  • Briana DD, Boutsikou M, Boutsikou T, et al. Plasma copeptin may not be a sensitive marker of perinatal stress in healthy full-term growth-restricted fetuses. J Matern Fetal Neonatal Med. 2017;30:705–709.
  • Briana DD, Boutsikou M, Athanasopoulos N, et al. Implication of the myokine irisin in maternal energy homeostasis in pregnancies with abnormal fetal growth. J Matern Fetal Neonatal Med. 2016;29:3429–3433.
  • Fukushima Y, Kurose S, Shinno H, et al. Relationships between serum irisin levels and metabolic parameters in Japanese patients with obesity. Obes Sci Practice. 2016;2:203–209.
  • Mehrabian S, Taheri E, Karkhaneh M, et al. Association of circulating irisin levels with normal weight obesity, glycemic and lipid profile. J Diabetes Metab Disord. 2015;15:17.
  • Liu H, Zhang S, Wang L, et al. Fasting and 2-hour plasma glucose, and HbA1c in pregnancy and the postpartum risk of diabetes among Chinese women with gestational diabetes. Diabetes Res Clin Pract. 2016;112:30–36.
  • Aziz S, Munim TF, Fatima SS. Post-partum follow-up of women with gestational diabetes mellitus: effectiveness, determinants, and barriers. J Matern Fetal Neonatal Med. 2018;31:1607–1612.
  • Liu Z, Ao D, Yang H, et al. Gestational weight gain and risk of gestational diabetes mellitus among Chinese women. Chin Med J (Engl). 2014;127:1255–1260.
  • Liu F, Liu Y, Lai YP, et al. Fetal hemodynamics and fetal growth indices by ultrasound in late pregnancy and birth weight in gestational diabetes mellitus. Chin Med J (Engl). 2016;129:2109–2114.
  • Marseille-Tremblay C, Ethier-Chiasson M, Forest JC, et al. Impact of maternal circulating cholesterol and gestational diabetes mellitus on lipid metabolism in human term placenta. Mol Reprod Dev. 2008;75:1054–1062.
  • Fukushima Y, Kurose S, Shinno H, et al. Effects of body weight reduction on serum irisin and metabolic parameters in obese subjects. Diabetes Metab J. 2016;40:386–395.
  • Jeon TI, Osborne TF. SREBPs: metabolic integrators in physiology and metabolism. Trends Endocrinol Metab. 2012;23:65–72.
  • Choi YK, Kim MK, Bae KH, et al. Serum irisin levels in new-onset type 2 diabetes. Diabetes Res Clin Pract. 2013;100:96–101.
  • Ural UM, Sahin SB, Tekin YB, et al. Alteration of maternal serum irisin levels in gestational diabetes mellitus. Ginekol Pol. 2016;87:395–398.
  • Zhao L, Li J, Li ZL, et al. Circulating irisin is lower in gestational diabetes mellitus. Endocr J. 2015;62:921–926.
  • Baka S, Malamitsi-Puchner A, Boutsikou T, et al. Cord blood irisin at the extremes of fetal growth. Metabolism. 2015;64:1515–1520.
  • Aydin S, Kuloglu T, Aydin S, et al. A comprehensive immunohistochemical examination of the distribution of the fat-burning protein irisin in biological tissues. Peptides. 2014;61:130–136.
  • Huh JY, Panagiotou G, Mougios V, et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism. 2012;61:1725–1738.
  • Aydin S, Aydin S, Kuloglu T, et al. Alterations of irisin concentrations in saliva and serum of obese and normal-weight subjects, before and after 45min of a Turkish bath or running. Peptides. 2013;50:13–18.
  • Lv J, Pan Y, Li X, et al. Study on the distribution and elimination of the new hormone irisin in vivo: new discoveries regarding irisin. Horm Metab Res. 2015;47:591–595.
  • Perakakis N, Triantafyllou GA, Fernández-Real JM, et al. Physiology and role of irisin in glucose homeostasis. Nat Rev Endocrinol. 2017;13:324–337.
  • Wrann CD. FNDC5/Irisin–their role in the nervous system and as a mediator for beneficial effects of exercise on the brain. Brain Plast. 2015;1:55–61.
  • Kurdiova T, Balaz M, Vician M, et al. Effects of obesity, diabetes and exercise on Fndc5 gene expression and irisin release in human skeletal muscle and adipose tissue: in vivo and in vitro studies. J Physiol. 2014;592:1091–1107.
  • Vergnes L, Chin RG, de Aguiar Vallim T, et al. SREBP-2-deficient and hypomorphic mice reveal roles for SREBP-2 in embryonic development and SREBP-1c expression. J Lipid Res. 2016;57:410–421.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.